Publication: Perioperative outcomes of percutaneous nephrolithotomy in septuagenarians and beyond
Issued Date
2021-09-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-85115436147
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.104, No.9 (2021), 1497-1502
Suggested Citation
Chinnakhet Ketsuwan, Charoen Leenanupunth, Wachira Kochakarn, Yada Phengsalae, Premsant Sangkum, Wisoot Kongchareonsombat Perioperative outcomes of percutaneous nephrolithotomy in septuagenarians and beyond. Journal of the Medical Association of Thailand. Vol.104, No.9 (2021), 1497-1502. doi:10.35755/jmedassocthai.2021.09.12781 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/77876
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Perioperative outcomes of percutaneous nephrolithotomy in septuagenarians and beyond
Other Contributor(s)
Abstract
Background: Life expectancy has continuously risen worldwide. Because the elderly may tolerate complications poorly, the risks and benefits of percutaneous nephrolithotomy (PCNL) in those patients should be discussed thoroughly. Objective: To analyze utility and operative outcomes of PCNL with respect to age. Materials and Methods: A retrospective study of PCNL was performed at Ramathibodi Hospital between 2011 and 2020. The patients were divided into two age groups, 1) below 70 years old and 2) 70 years old and above. Comparison of demographics, operative data, and postoperative outcomes were analyzed. Results: Of the 253 patients, the overall stone-free rate (SFR) was 59.7%. The SFR in younger groups and older groups were 59.4% (126/212) and 61.0% (25/41), respectively, which was not significantly different (p=0.999). There was a similar in-stone burden between the two groups (p=0.573). Patients in the older group had worse renal function, higher American Society of Anesthesiologists score, and more comorbidities, including hypertension and ischemic heart disease. However, estimated blood loss, length of hospital stay, operative time, percent change in eGFR, and complications were comparable between the groups. Conclusion: PCNL is a safe and effective treatment of kidney calculi in septuagenarians and older patients, even with the risk of higher comorbidities and poorer renal function than in younger patients.